SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,933.59 -539.35
( -0.70%)

Global Indices

Nasdaq

53,487.87 -110.53
(-0.21%)

Dow Jones

7,697.38 -0.90
(-0.01%)

Hang Seng

66,058.92 -203.24
(-0.31%)

Nikkei 225

10,795.58 -82.54
(-0.76%)

Forex

USD-INR

95.31 -0.39
(-0.41%)

EUR-INR

111.19 -0.48
(-0.43%)

GBP-INR

129.97 -0.53
(-0.40%)

JPY-INR

0.60 0.00
(-0.54%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

RBM Infracon Ltd

Industry : Construction

BSE Code

ISIN Demat

Book Value()

77929

INE0NA301016

176.4628985

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

RBMINFRA

5.76

260.88

EPS(TTM)

Face Value()

Div & Yield %

42.59

Back

Bafna Pharmaceuticals standalone net profit rises 93.68% in the December 2025 quarter

Feb 12,2026

Net profit of Bafna Pharmaceuticals rose 93.68% to Rs 1.84 crore in the quarter ended December 2025 as against Rs 0.95 crore during the previous quarter ended December 2024. Sales rose 15.37% to Rs 38.29 crore in the quarter ended December 2025 as against Rs 33.19 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	38.29	33.19	15
OPM %	7.97	9.25	-
PBDT	3.41	2.62	30
PBT	1.84	0.96	92
NP	1.84	0.95	94

76,933.59 -539.35 ( -0.70%)

53,487.87 -110.53 (-0.21%)

7,697.38 -0.90 (-0.01%)

66,058.92 -203.24 (-0.31%)

10,795.58 -82.54 (-0.76%)

95.31 -0.39 (-0.41%)

111.19 -0.48 (-0.43%)

129.97 -0.53 (-0.40%)

0.60 0.00 (-0.54%)